Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans
Abstract Inflammatory bowel disease (IBD) is difficult to diagnose due to nonspecific and variable symptoms, and lack of reliable diagnostic tests. Current methods are invasive, non-sensitive, non-predictive, and do not easily discriminate between its two main forms. Consequently, there remains a gr...
Guardado en:
Autores principales: | Emilie Viennois, Yuan Zhao, Moon Kwon Han, Bo Xiao, Mingzhen Zhang, Meena Prasad, Lixin Wang, Didier Merlin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae240fd4a54240fc99acb54a6dce06c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008) -
Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis
por: Hesham Aly Salem, et al.
Publicado: (2017) -
Golimumab in unresponsive ulcerative colitis
por: Lippert E, et al.
Publicado: (2014) -
Analysis of the Anti-Inflammatory Capacity of Bone Broth in a Murine Model of Ulcerative Colitis
por: Laura M. Mar-Solís, et al.
Publicado: (2021) -
Is histological remission of ulcerative colitis achievable?
por: Oleg V. Knyazev, et al.
Publicado: (2021)